Back to Search
Start Over
Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study
- Source :
- BMC Psychiatry, Vol 24, Iss 1, Pp 1-6 (2024)
- Publication Year :
- 2024
- Publisher :
- BMC, 2024.
-
Abstract
- Abstract Background To analyze the economic benefits of paliperidone palmitate in the treatment of schizophrenia. Methods We collected 546 patients who met the diagnostic criteria for schizophrenia according to the 《International Statistical Classification of Diseases and Related Health Problems,10th》(ICD-10). We gathered general population data such as gender, age, marital status, and education level, then initiated treatment with paliperidone palmitate. Then Follow-up evaluations were conducted at 1, 3, 6, 9, and 12 months after the start of treatment to assess clinical efficacy, adverse reactions, and injection doses. We also collected information on the economic burden before and after 12 months of treatment, as well as the number of outpatient visits and hospitalizations in the past year to analyze economic benefits. Results The baseline patients totaled 546, with 239 still receiving treatment with paliperidone palmitate 12 months later. After 12 months of treatment, the number of outpatient visits per year increased compared to before (4 (2,10) vs. 12 (4,12), Z=-5.949, P 0.05); the indirect costs of patients after 12 months of treatment (lost productivity costs for patients and families, economic costs due to destructive behavior, costs of seeking non-medical assistance) decreased compared to before (300(150,600) vs. 150(100,200), P
- Subjects :
- Schizophrenia
Paliperidone palmitate
Economic benefits
Psychiatry
RC435-571
Subjects
Details
- Language :
- English
- ISSN :
- 1471244X
- Volume :
- 24
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- BMC Psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.319854e85b9145309624c666ef2d41c7
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s12888-024-05874-1